Heron Therapeutics (HRTX) Free Cash Flow (2010 - 2026)
Heron Therapeutics' (HRTX) quarterly Free Cash Flow came in at -$1.9 million in Q1 2026, up 78.49% YoY from -$1.1 million in Q1 2025, and up 78.97% on a QoQ basis from -$9.2 million in Q4 2025.
Heron Therapeutics (HRTX) Free Cash Flow (2010 - 2026) Analysis & Trends
Heron Therapeutics (HRTX) has 17 years of Free Cash Flow data on file, last reported at -$1.9 million in Q1 2026.
- Quarterly Free Cash Flow rose 78.49% year-over-year to -$1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$20.9 million (up 9.54% YoY) and the FY2025 annual result came in at -$27.9 million, down 15.16% from the prior year.
- Free Cash Flow advanced to -$1.9 million in Q1 2026, from -$9.2 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $2.9 million in Q3 2024 to a low of -$45.0 million in Q1 2022.
- A 5-year average of -$15.4 million and a median of -$10.0 million in 2023 frame the typical range for Free Cash Flow.
- The widest YoY moves for Free Cash Flow: up 129.48% in 2024, down 663.17% in 2024.
- Tracing HRTX's Free Cash Flow over 5 years: stood at -$37.9 million in 2022, then jumped by 105.81% to $2.2 million in 2023, then plunged by 663.17% to -$12.4 million in 2024, then climbed by 26.04% to -$9.2 million in 2025, then jumped by 78.97% to -$1.9 million in 2026.
- The last three Free Cash Flow figures came in at -$1.9 million (Q1 2026), -$9.2 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | Heron Therapeutics | 59.96 Mn | 17.29 Mn | 26.09 Mn | -2.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.35 Mn |
| Jun 30, 2026 | -2.35 Mn |
| Mar 31, 2026 | -1.93 Mn |
| Mar 31, 2026 | -1.93 Mn |
| Dec 31, 2025 | -9.18 Mn |
| Dec 31, 2025 | -9.18 Mn |
| Sep 30, 2025 | 1.33 Mn |
| Sep 30, 2025 | 1.33 Mn |
| Jun 30, 2025 | -11.08 Mn |
| Jun 30, 2025 | -11.08 Mn |
| Mar 31, 2025 | -8.98 Mn |
| Mar 31, 2025 | -8.98 Mn |
| Dec 31, 2024 | -12.42 Mn |
| Dec 31, 2024 | -12.42 Mn |
| Sep 30, 2024 | 2.94 Mn |
| Sep 30, 2024 | 2.94 Mn |
| Jun 30, 2024 | -4.60 Mn |
| Jun 30, 2024 | -4.60 Mn |
| Mar 31, 2024 | -9.52 Mn |
| Mar 31, 2024 | -9.52 Mn |